Skip to main content
Clinical Trials/ACTRN12607000598482
ACTRN12607000598482
Completed
Phase 1

A study in healthy adults of a randomised, controlled vaccine intervention study evaluating the safety and immunogenicity of a Hepatitis B vaccine containing Advax adjuvant

Vaxine Pty Ltd0 sites24 target enrollmentNovember 21, 2007

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hepatitis B prevention
Sponsor
Vaxine Pty Ltd
Enrollment
24
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 21, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 18\-40
  • Healthy male or female
  • Non\-pregnant
  • If child bearing age, using contraception (barrier method, intrauterine device (IUD) or oral contraception)
  • No history or evidence of Hep B infection or vaccination
  • No history of blood transfusion within last 6 months
  • Able to provide written informed consent
  • Willing and able to comply with the protocol for the duration of the study.

Exclusion Criteria

  • Serum positive for antibodies to hepatitis B virus (HBV) or for HBV antigens
  • History of hepatitis B vaccination
  • Previous Hepatitis B infection
  • Immunodeficiency
  • Diabetes mellitus
  • Significant Liver disease (any liver enzyme \> 1\.5 times upper limit normal)
  • Kidney disease (Calculated creatinine clearance female \< 60 ml/min, male \<60 ml/min).
  • Any serious systemic illness last 6 months
  • History of vaccine allergy
  • Women of childbearing potential unless using a reliable and appropriate contraceptive method, specifically oral contraceptive pill, IUD or mechanical barrier device.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
Trial of swine influenza vaccine in healthy adultsSwine influenzaInfection - Other infectious diseases
ACTRN12609000674235Vaxine Pty Ltd300
Recruiting
Not Applicable
Trialing a fruit and vegetable intervention to promote a healthy weight and reduce disease riskPoor dietary intakeDiet and Nutrition - Other diet and nutrition disorders
ACTRN12619001415190The University of Newcastle120
Completed
Phase 3
An exploration of the antioxidant, immunomodulatory, and anti-inflammatory activities of Ambrotose in healthy individuals.Immune system function in healthy individualsAntioxidant levels in healthy individualsInflammatory and Immune System - Normal development and function of the immune systemAlternative and Complementary Medicine - Herbal remedies
ACTRN12608000078358Mannatech, Inc60
Not yet recruiting
Not Applicable
Comparing fibreoptic-guided tracheal intubation using two supraglottic devices: Ambu AuraGain Laryngeal Mask Airway 'Registered Trademark' and LMA Fastrach 'Registered Trademark'
ACTRN12615000300572Elizabeth Judson120
Terminated
Not Applicable
Managing Chronic Obstructive Pulmonary Disease(COPD)Together: Participant-CENTREd Continuum of Care (PCCC). A comparison of telephone health-mentoring, home-based walking and rehabilitation with rehabilitation only.Chronic Obstructive Pulmonary Disease (COPD)Respiratory - Chronic obstructive pulmonary diseasePhysical Medicine / Rehabilitation - Physiotherapy
ACTRN12611001034921Menzies Research Institute Tasmania, University of Tasmania74